Cellular Origins has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform for autologous CAR-T cell manufacturing.

Celltrio closes $15 million funding round to expand automated cell culture and gene therapy solutions across North America ...

The global cell therapy technologies market is set to witness a growth rate of 12% in the next 5 years. Rising prevalence of ...

Ori and MaxCyte have selected CD19 CAR expression via CRISPR knock-in in activated T cells as the test system for initial ...

Involt Energy has entered solar cell manufacturing with a 1.78 GW fully automated facility in western India. The company plans to begin ramp-up by mid 2026 with an additional 3 GW cell line and a 3 GW ...

The Gujarat Electronics Component Manufacturing Policy 2025 aims to reduce import dependency, promote local manufacturing, and attract over ₹35,000 crore in investments, ensuring quick disbursement of ...

Instead of extracting T-cells and engineering them in a lab, researchers have delivered mRNA directly into circulating immune ...

The ExPERT and IRO platforms were integrated to improve the yield of gene-edited T cells and shorten manufacturing timelines.

After acquiring the U.S. manufacturing assets of Trina Solar, Freyr Battery announced in February it was rebranding as T1 ...

Miltenyi Biotec India and Biotechnology Industry Research Assistance Council (BIRAC) have signed a letter of intent for a collaboration aimed at enhancing India’s capabilities in cell and gene therapy ...

The Thousand Oaks, Calif., cell therapy manufacturing facility now houses new production suites, updated development labs, and more after expansion. Manufacturers of five autologous or matched ...

Our Bureau, Mumbai Wednesday, June 18, 2025, 16:30 Hrs [IST] ...